A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
Clinical trial NCT06500507 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06500507
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2026-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.